Introduction :
Acute coronary syndrome (ACS) includes unstable angina (UA), non ST-elevation myocardial infarction (NSTEMI) and ST-elevation myocardial infarction (STEMI). All three conditions share a common pathophysiology, characterized by acute coronary insufficiency due to disruption of a vulnerable plaque with superadded thrombus formation with or without vasospasm following rupture of atheromatous plaque. By the year 2020 it is estimated that it will be the major cause of death in all regions of the world and will hold the first place in the World Health Organization's list of leading cause of disability. Coronary artery disease has been recognized as one of the leading cause of death in our country. Prevalence of IHD in urban population of Bangladesh was 100 per thousand 4 . The main complications were pump failure (53%) and ventricular fibrillation (27%). The mortality of untreated AMI was 40% and 50% of them died with in the first two hours of the onset of AMI 4 . Mortality is high in case of cardiogenic shock in all age groups. Between these two extremes, However, these treatment options are expensive and with risk of complications. Risk stratification can be used to identify patients who would derive particular benefit from these therapies 6 . TIMI risk index is likely to be clinically useful to predict the short term prognosis and help in planning in early management of patients and may also serve as a valuable aid in designing clinical research. To be practical clinically, a risk stratification tool should be simple & easily applied at the bedside and should make use of clinical data that are routinely available at hospital presentation. In our country, however no such clinical prognostic tool has been developed or evaluated as yet. This study is designed to assess and develop a clinical bedside prognostic tool for risk assessment in ACS.
Methods:
Patients with a diagnosis of ACS attending cardiac emergency of BSMMU hospital taken as sample. Statistical significance of difference was analyzed with appropriate formula. P value of less than 0.05 was considered as significant.
Results:
This was a prospective study conducted in Bangabandhu Sheikh Mujib Medical University, Dhaka. The main objective of the study was to predict, 30 days Major Adverse Cardiac Events (MACE) by using TIMI risk index. Total 279 patients of ACS were enrolled in the study. Of them 132 were UA/NSTEMI group and 147 were in STEMI group. The findings of the study and its prediction are showed in Table I Not significant, * = significant at P<0.05, ** = significant at P <0.01, ***= Significant at P<0.001. ns = Not significant, * = significant at P<0.05, ** = significant at P <0.01, ***= Significant at P<0.001. Statistical analysis done by Cox regression. ns = Not significant, * = significant at P<0.05, ** = significant at P <0.01, ***= Significant at P<0.001. . This study showed 30 days MACE were lower in TRI group 1 in both UA/NSTEMI and STEMI group. In UA/NSTEMI group, MACE of TRI group 2 was also lower. MACE were higher in TRI group 3, 4 and 5 in case of UA/NSTEMI. MACE were higher in TRI group 2, 3, 4 and 5 in case of STEMI. This difference might be due to small sample size of study.
Conclusion:
This study tested risk stratification strategies on a group of ACS patient. The TIMI risk index may be readily applied as a prognostic tool at the bed side of hospital and may forecast the major adverse prognostic information. This risk management tool is likely to be clinically useful in the triage and management of patients eligible for fibrinolytic therapy as well as early revascularization. TIMI risk index for UA/NSTEMI & STEMI may be readily applied at the bedside at the time of hospital presentation. Patients with higher TIMI risk index at presentation needs early invasive management to reduce MACE. Although most of the results of this study have come up with the statistically significant findings, there are some facts to be considered which might affect the result. These are limited number of subjects and short follow up period.
